SCHEMBL20701748

SCHEMBL20701748

CCCCC(C)Oc1nc(N)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.47
ADORA2B P29275 8/20 0.47
TP53 P04637 1/20 0.47
CYP2C9 P11712 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
APEX1 P27695 1/20 0.47
PI4KA P42356 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
ADCY1 Q08828 1/20 0.47
PI4K2B Q8TCG2 1/20 0.47
PI4K2A Q9BTU6 1/20 0.47
PI4KB Q9UBF8 1/20 0.47
YTHDC1 Q96MU7 1/20 0.46
CYP2C19 P33261 1/20 0.42
TLR7 Q9NYK1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566979 1.00 ADORA2A (0.47) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL1851384 0.94 ADORA2A (0.48) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL2197022 0.94 ADORA2A (0.48) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL566598 0.94 ADORA2A (0.48) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL29697253 0.94 ADORA2A (0.48) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL11454503 0.90 ADORA2A (0.57) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL565983 0.90 ADORA2A (0.57) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL20275530 0.88 YTHDC1 (0.60) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL2197420 0.87 TP53 (0.48) ADORA2AADORA2BTP53CYP2C9NFKB1
SCHEMBL29809280 0.86 ADORA2A (0.55) ADORA2AADORA2BTP53CYP2C9NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190038631-A1 6-AMINO-PURIN-8-ONE COMPOUNDS GLAXOSMITHKLINE LLC 2019-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190038631-A1 6-AMINO-PURIN-8-ONE COMPOUNDS IFNG, IFNAR1, IRF3 ADORA2A 78/4885ADORA2B 46/4885TP53 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.